Cumberland Pharmaceuticals (CPIX) Tops Q4 EPS by 2c, Revenues Beat

March 9, 2021 4:23 PM EST
Get Alerts CPIX Hot Sheet
Price: $2.99 -1.64%

Today's EPS Names:
CVU, BK, KSU, More
Trade Now! 
Join SI Premium – FREE

Get instant alerts when news breaks on your stocks. Claim your 1-week free trial to StreetInsider Premium here.

Cumberland Pharmaceuticals (NASDAQ: CPIX) reported Q4 EPS of $0.01, $0.02 better than the analyst estimate of ($0.01). Revenue for the quarter came in at $10.26 million versus the consensus estimate of $9.78 million.

"We are grateful that Cumberland was able to successfully manage through the pandemic during 2020, in spite of the significant market headwinds and other challenges we encountered," said A.J. Kazimi, Chief Executive Officer of Cumberland Pharmaceuticals. "Our facilities remained open, our operations continued, and our organization remained intact." He continued, "I would like to acknowledge and thank my colleagues for their continued dedication during such trying times for many. Together, we remain focused on our mission of advancing patient care through the delivery of high-quality medicines."

For earnings history and earnings-related data on Cumberland Pharmaceuticals (CPIX) click here.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Corporate News, Earnings, Management Comments

Related Entities